Literature DB >> 32620562

Finding Camel-ot: A Holy Grail against pandemic SARS-CoV-2?

Deborah Soong1, Rachel Leeman1, Asha Pillai2.   

Abstract

Engineered camelid antibody multimers can potently block SARS-CoV-2 viral entry.
Copyright © 2020, American Association for the Advancement of Science.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32620562      PMCID： PMC7886180          DOI： 10.1126/sciimmunol.abd4758

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  1 in total

1.  Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Authors:  Daniel Wrapp; Dorien De Vlieger; Kizzmekia S Corbett; Gretel M Torres; Nianshuang Wang; Wander Van Breedam; Kenny Roose; Loes van Schie; Markus Hoffmann; Stefan Pöhlmann; Barney S Graham; Nico Callewaert; Bert Schepens; Xavier Saelens; Jason S McLellan
Journal:  Cell       Date:  2020-06-11       Impact factor: 41.582
  1 in total
  2 in total

Review 1.  SARS-CoV-2 infection causes intestinal cell damage: Role of interferon's imbalance.

Authors:  Stefany Guimarães Sousa; Antônio Kleiton de Sousa; Cynthia Maria Carvalho Pereira; Anna Sofia Miranda Loiola Araújo; Diva de Aguiar Magalhães; Tarcisio Vieira de Brito; André Luiz Dos Reis Barbosa
Journal:  Cytokine       Date:  2022-02-10       Impact factor: 3.861

Review 2.  Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article.

Authors:  AbdulRahman A Saied; Asmaa A Metwally; Moses Alobo; Jaffer Shah; Khan Sharun; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-01-19       Impact factor: 6.071
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.